home > drugs a-z list > somavert (pegvisomant) drug center > somavert (pegvisomant) drug - patient avoid while taking

In this Article

• What is pegvisomant (Somavert)?
• What are the possible side effects of pegvisomant (Somavert)?
• What is the most important information I should know about pegvisomant (Somavert)?
• What should I discuss with my health care provider before taking pegvisomant (Somavert)?
• How should I take pegvisomant (Somavert)?
• What happens if I miss a dose (Somavert)?
• What happens if I overdose (Somavert)?
• What should I avoid while taking pegvisomant (Somavert)?
• What other drugs will affect pegvisomant (Somavert)?
• Where can I get more information?

What happens if I miss a dose (Somavert)?

If you miss a dose of pegvisomant, skip the missed dose and use only the next regularly scheduled dose the next day. Do not use a double dose of this medication.

What happens if I overdose (Somavert)?

Seek emergency medical attention or contact your doctor immediately if an overdose of pegvisomant is suspected.

Symptoms of a pegvisomant overdose may include fatigue.

What should I avoid while taking pegvisomant (Somavert)?

There are no restrictions on food, beverages, or activity during treatment with pegvisomant unless otherwise directed by your healthcare provider.

What other drugs will affect pegvisomant (Somavert)?

Before taking pegvisomant, tell your doctor if you are taking any of the following medicines:

• insulin;
• any medicine taken by mouth to treat diabetes such as glyburide (Diabeta, Glynase, Micronase), glipizide (Glucotrol), glimepiride (Amaryl), rosiglitazone (Avandia), pioglitazone (Actos), and others; or
• a narcotic pain or cough medication such as codeine (Tylenol #3, others), hydrocodone (Vicodin, Lorcet, others), oxycodone (Percocet, others), morphine (MS Contin, MSIR, OxyContin, others), fentanyl (Duragesic, others), and others.

You may not be able to take pegvisomant, or you may require a dosage adjustment or special monitoring during treatment if you are taking any of the medicines listed above.

Drugs other than those listed here may also interact with pegvisomant. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products.

Where can I get more information?

Your pharmacist has additional information about pegvisomant that you may read.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2010 Cerner Multum, Inc. Version: 2.02. Revision date: 4/12/2009.

Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.